Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Zacks Short Term Rating on Fresenius Medical Care Corporation (NYSE:FMS) - News Watch International |
 |
 |
|
Fresenius Medical Care Corporation (NYSE:FMS) is a hold, according to the latest average broker rating of 2.63. The number of analysts in this rating is 8. Research Analysts at Zacks has the Shares a rating of 3, which implies that the firms recommendation is Neutral on the company. Fresenius Medical Care Corporation (NYSE:FMS): 4 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $43.91 in Fresenius Medical Care Corporation (NYSE:FMS). However, the stock price could fluctuate by $ 4.67 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $50 price target with the lower price estimate is calculated at $39 The company shares have rallied 34.47% in the past 52 Weeks. On June 4, 2015 The shares registered one year high of $44.34 and one year low was seen on June 24, 2014 at $32.05. The 50-day moving average is $42.8 and the 200 day moving average is recorded at $40.13. S&P 500 has rallied 8.87% during the last 52-weeks. Fresenius Medical Care Corporation (NYSE:FMS) rose 0.16% or 0.07 points on Tuesday and made its way into the gainers of the day. After trading began at $43.14 the stock was seen hitting $43.29 as a peak level and $43.11 as the lowest level. The stock ended up at $43.18. The daily volume was measured at 121,698 shares. The 52-week high of the share price is $44.34 and the 52-week low is $31.96. The company has a market cap of $26,925 million. Fresenius Medical Care AG & Co KGaA is a Germany-based kidney dialysis company that operates in the fields of dialysis care and dialysis products for the treatment of end-stage renal disease (ESRD). Its dialysis business is vertically integrated and offers products and services for the entire dialysis value chain, providing dialysis treatment at dialysis clinics it owns or operates and supplying these clinics with a range of products. The Company offers two types of dialysis treatment: Hemodialysis (HD), where the machine controls the blood from the patient through a special filter, the dialyzer, and Peritoneal Dialysis (PD), where the patients peritoneum is used as a dialyzing membrane. Its dialysis product portfolio includes chronic hemodialysis, home dialysis, renal pharmaceuticals, acute therapy, liver support, therapeutic apheresis, therapy support and water technology, among others. In addition, the Company sells dialysis products to other dialysis service providers. NO COMMENTS LEAVE A REPLY Cancel reply |
